Mild hyperbilirubinaemia as an endogenous mitigator of overweight and obesity: Implications for improved metabolic health

Atherosclerosis. 2018 Feb:269:306-311. doi: 10.1016/j.atherosclerosis.2017.12.021. Epub 2017 Dec 14.

Abstract

Background and aims: Mild endogenous elevation of unconjugated bilirubin (UCB) as seen in Gilbert's syndrome (GS), might mitigate cardiovascular disease (CVD) risk factors including overweight/obesity. This study aimed to determine whether hyperbilirubinaemia is linked to improved anthropometric data and lipid profile.

Methods: Our study considered GS and age-/gender-matched healthy controls (n = 248). Additionally, obese female type 2 diabetic patients (DM2) (n = 26) were included as a "disease control group".

Results: BMI, hip circumference (HC), and lipid profile were significantly lower in GS. UCB was inversely correlated with BMI (p <0 .001), HC as well as with fat mass (FM) and lipid variables (p < 0.05). Moreover, DM2 patients had significantly lower UCB compared to GS and healthy controls. Older GS subjects (≥35 years) had significantly reduced anthropometric data and improved lipid profile.

Conclusions: Our results propose that the health promoting potential of mild hyperbilirubinaemia may extend to protection from age-related weight gain and dyslipidaemia.

Keywords: Anthropometric data; Bilirubin; Cardiovascular disease (CVD) risk factors; Lipid profile; Overweight/obesity; Unconjugated bilirubin (UCB).

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiposity
  • Adult
  • Age Factors
  • Austria / epidemiology
  • Bilirubin / blood*
  • Biomarkers / blood
  • Body Mass Index
  • Case-Control Studies
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / epidemiology
  • Dyslipidemias / blood
  • Dyslipidemias / diagnosis
  • Dyslipidemias / epidemiology
  • Dyslipidemias / prevention & control*
  • Female
  • Gilbert Disease / blood*
  • Gilbert Disease / diagnosis
  • Gilbert Disease / epidemiology
  • Health Status
  • Humans
  • Lipids / blood*
  • Male
  • Middle Aged
  • Obesity / blood
  • Obesity / diagnosis
  • Obesity / epidemiology
  • Obesity / prevention & control*
  • Prevalence
  • Protective Factors
  • Risk Factors
  • Up-Regulation
  • Weight Gain
  • Young Adult

Substances

  • Biomarkers
  • Lipids
  • Bilirubin